Page 1 of 403
WEEK 7 & 8 FINAL EXAM: NR546 / NR-546 (LATEST
UPDATE STUDY BUNDLE WITH COMPLETE
SOLUTIONS) ADVANCED PHARMACOLOGY
PSYCHOPHARMACOLOGY FOR THE PMHNP |
QUESTIONS & VERIFIED ANSWERS | GRADE A -
CHAMBERLAIN
What should the PMHNP consider when prescribing chemical
restraints? .....ANSWER.....-allergy status
-prior med hx for adverse drug reactions r/t the meds ordered
in the chemical restraint
-state regulations regarding chemical restrains must be reviewed
Are the PMHNP and other staff liable if the client has an allergic
reaction or adverse side effects to the drugs used for chemical
restraint? .....ANSWER.....No.
,Page 2 of 403
The client has been court-ordered to take the prescribed
medications and the standing order for chemical restraints is
approved. The PMHNP and other staff are not liable if the
patient has an allergic reaction or adverse side effects.
How does reviewing the genetic makeup of a client help guide
the PMHNP in selecting medication for clients? .....ANSWER.....-
Genetic testing can assist by providing more information on how
clients may respond to certain psychotropic medications
-provides information on how a client may break down and
metabolize medications based on the cytochrome P450 system.
Tanrıkulu and Erbaş (2020) investigated identical twins to
determine the presence of an inherited link for schizophrenia and
why one twin may develop schizophrenia when the other does
not. When two people have 100% identical DNA, why don't
both persons develop the exact illnesses? Studies of identical
Danish twins found that if one twin had schizophrenia, the other
,Page 3 of 403
twin had a 50% lifetime risk of developing schizophrenia
(Lemvigh et al., 2020). Why is there only half the risk?
.....ANSWER.....Both environmental and psychosocial stressors can
impact mental health. Although twins may have identical genes,
their gene expression may be different.
There may be an environmental exposure that turned a gene
"on" that should have been "off" for one twin to develop
schizophrenia and not the other.
central sulcus .....ANSWER.....separates the frontal lobe from the
parietal lobe
frontal lobe .....ANSWER.....associated with movement,
intelligence, abstract thinking
broca's area .....ANSWER.....speech production
, Page 4 of 403
temporal lobe .....ANSWER.....involves object identification and
auditory signals
cerebellum .....ANSWER.....coordination
wernicke's area .....ANSWER.....speech comprehension
occipital lobe .....ANSWER.....primary visual area
parietal lobe .....ANSWER.....keeps us alert to what is going on
around us
sensory cortex .....ANSWER.....pain, heat, and other sensations
motor cortex .....ANSWER.....movement
hippocampus .....ANSWER.....involved in both memory and
anxiety
nucleus accumbens .....ANSWER.....involved in the reward process
thalamus .....ANSWER.....involved in sensory organ and motor
command processing
WEEK 7 & 8 FINAL EXAM: NR546 / NR-546 (LATEST
UPDATE STUDY BUNDLE WITH COMPLETE
SOLUTIONS) ADVANCED PHARMACOLOGY
PSYCHOPHARMACOLOGY FOR THE PMHNP |
QUESTIONS & VERIFIED ANSWERS | GRADE A -
CHAMBERLAIN
What should the PMHNP consider when prescribing chemical
restraints? .....ANSWER.....-allergy status
-prior med hx for adverse drug reactions r/t the meds ordered
in the chemical restraint
-state regulations regarding chemical restrains must be reviewed
Are the PMHNP and other staff liable if the client has an allergic
reaction or adverse side effects to the drugs used for chemical
restraint? .....ANSWER.....No.
,Page 2 of 403
The client has been court-ordered to take the prescribed
medications and the standing order for chemical restraints is
approved. The PMHNP and other staff are not liable if the
patient has an allergic reaction or adverse side effects.
How does reviewing the genetic makeup of a client help guide
the PMHNP in selecting medication for clients? .....ANSWER.....-
Genetic testing can assist by providing more information on how
clients may respond to certain psychotropic medications
-provides information on how a client may break down and
metabolize medications based on the cytochrome P450 system.
Tanrıkulu and Erbaş (2020) investigated identical twins to
determine the presence of an inherited link for schizophrenia and
why one twin may develop schizophrenia when the other does
not. When two people have 100% identical DNA, why don't
both persons develop the exact illnesses? Studies of identical
Danish twins found that if one twin had schizophrenia, the other
,Page 3 of 403
twin had a 50% lifetime risk of developing schizophrenia
(Lemvigh et al., 2020). Why is there only half the risk?
.....ANSWER.....Both environmental and psychosocial stressors can
impact mental health. Although twins may have identical genes,
their gene expression may be different.
There may be an environmental exposure that turned a gene
"on" that should have been "off" for one twin to develop
schizophrenia and not the other.
central sulcus .....ANSWER.....separates the frontal lobe from the
parietal lobe
frontal lobe .....ANSWER.....associated with movement,
intelligence, abstract thinking
broca's area .....ANSWER.....speech production
, Page 4 of 403
temporal lobe .....ANSWER.....involves object identification and
auditory signals
cerebellum .....ANSWER.....coordination
wernicke's area .....ANSWER.....speech comprehension
occipital lobe .....ANSWER.....primary visual area
parietal lobe .....ANSWER.....keeps us alert to what is going on
around us
sensory cortex .....ANSWER.....pain, heat, and other sensations
motor cortex .....ANSWER.....movement
hippocampus .....ANSWER.....involved in both memory and
anxiety
nucleus accumbens .....ANSWER.....involved in the reward process
thalamus .....ANSWER.....involved in sensory organ and motor
command processing
